跳至主要内容
临床试验/CTRI/2015/01/005413
CTRI/2015/01/005413已完成3 期

â??To study the effect of tadalafil on exercise capacity and cardiopulmonary haemodynamics in chronic pulmonary disease patients with pulmonary arterial hypertension: A hospital based prospective randomized controlled trialâ??.

il0 个研究点目标入组 100 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Adult males or females with a diagnosis of
  • chronic pulmonary disease with PAH.
  • 2.Patients between 20 to 80 years of age.
  • 3.Willingness to participate in the study.

排除标准

  • 1.History or clinical evidence of chronic
  • pulmonary diseases without PAH.
  • 2.Patients of Coronary artery disease,
  • chronic kidney disease, liver disease,
  • Left ventricular failure.
  • 3.Patients with myopathy/muscular dystrophy
  • 4.Patients with Peripheral vascular
  • disease/Osteoarthritis of Knees
  • 5.Pregnancy
  • 6.Patients aged less than 20 years and more
  • than 80 years
  • 7.Drug history of Anorexigens
  • 8.Patients with HIV
  • 9.Patient unwilling to participate in the

研究者

发起方
il

相似试验